Dicerna Pharmaceuticals Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
46,595.00
96,122.00
94,609.00
45,874.00
113,678.00
302,626
Total Accounts Receivable
-
55.00
-
295.00
2,001.00
100,000
Other Current Assets
262.00
1,139.00
1,532.00
1,657.00
2,879.00
2,888
Total Current Assets
46,857.00
97,316.00
96,141.00
47,826.00
118,558.00
405,514
Net Property, Plant & Equipment
877.00
2,165.00
2,684.00
2,234.00
1,512.00
2,718
Total Investments and Advances
264.00
3,881.00
1,116.00
1,116.00
744.00
744
Other Assets
1,796.00
243.00
82.00
76.00
70.00
65
Total Assets
49,794.00
103,605.00
100,023.00
51,252.00
120,884.00
409,041
ST Debt & Current Portion LT Debt
4,587.00
-
-
-
-
Accounts Payable
1,700.00
-
2,621.00
4,318.00
4,920.00
Other Current Liabilities
1,391.00
5,159.00
6,380.00
5,726.00
11,726.00
Total Current Liabilities
7,678.00
5,159.00
9,001.00
10,044.00
16,646.00
Long-Term Debt
789.00
-
-
-
-
Other Liabilities
-
106.00
-
-
3,000.00
Total Liabilities
8,467.00
5,265.00
9,001.00
10,044.00
19,646.00
Common Equity (Total)
68,919.00
98,340.00
91,022.00
41,208.00
101,238.00
Total Shareholders' Equity
41,327.00
98,340.00
91,022.00
41,208.00
101,238.00
Total Equity
41,327.00
98,340.00
91,022.00
41,208.00
101,238.00
Liabilities & Shareholders' Equity
49,794.00
103,605.00
100,023.00
51,252.00
120,884.00
Preferred Stock (Carrying Value)
110,246.00
-
-
-
-
About Dicerna Pharmaceuticals
View Profile
